Pumitamig

SEP 8, 2026 · PHASE 3 TRIAL

A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)

ClinicalTrials.gov

This is a registered Phase 3 trial currently recruiting with no results posted; it describes a planned comparison but carries no outcome data.

SEP 8, 2026 · PHASE 3 TRIAL

ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer

ClinicalTrials.gov

This is a clinical trial registry record describing a Phase 3 RCT that is currently recruiting with no results posted; the study design is rigorous but outcomes are not yet available.

AUG 18, 2026 · PHASE 1/2 TRIAL

A Study to Assess the Safety and Tolerability of BMS-986525 Alone and in Combination Therapy in Participants With Relapsed/Refractory Small Cell Lung Cancer

ClinicalTrials.gov

Phase 1/2 safety and tolerability trial in an active recruitment phase with no results posted; this is a planned study registration documenting trial design and safety endpoints only.

AUG 13, 2026 · PHASE 2/3 TRIAL

Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer

ClinicalTrials.gov

This is a recruiting Phase 2/3 trial registration with no reported results; primary outcomes remain unassessed and data are not yet available to evaluate efficacy or safety.